Product Program year 2025 Source: CMS Open Payments

Claw II

Device Trauma & Extremities

PDI 00840420110794

Open in the dashboard

General payments

$1,592,099

711 payments

Research payments

$38,650

2 payments

Through program year 2025, $1,592,099 in general payments and $38,650 in research payments were reported against Claw II (Trauma & Extremities).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $31,180 86
2024 General $106,369 122
2023 General $330,591 147
2022 General $627,790 192
2022 Research $37,500 1
2021 General $496,168 164
2021 Research $1,150 1

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $1,592,099 711 payments
Top recipients General payments · program year 2025
  1. Douglas Blacklidge Podiatrist, Foot & Ankle Surgery · Kokomo, IN $23,993 77% · 4 payments
  2. Stephen Cox Orthopaedic Surgery · Shreveport, LA $161 <1% · 3 payments
  3. Dustin Lybeck Adult Reconstructive Orthopaedic Surgery · Fort Sam Houston, TX $153 <1% · 1 payment
  4. Raymond Kessler Orthopaedic Trauma · Fort Sam Houston, TX $153 <1% · 1 payment
  5. Katherine Bedigrew Foot and Ankle Surgery · San Antonio, TX $153 <1% · 1 payment

The top 5 of 78 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Podiatrist, Foot & Ankle Surgery Podiatrist $24,538 83% · 14 practitioners
  2. General Practice $2,293 8% · 15 practitioners
  3. Orthopaedic Surgery $1,204 4% · 9 practitioners
  4. Orthopaedic Trauma Orthopaedic Surgery $459 2% · 3 practitioners
  5. Podiatrist $346 1% · 5 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Indiana $23,993 77% · 1 recipient
  2. Texas $3,644 12% · 26 recipients
  3. Louisiana $1,462 5% · 15 recipients
  4. Michigan $230 <1% · 3 recipients
  5. Pennsylvania $228 <1% · 10 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

711 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record